In a Phase I clinical trial, the drug demonstrated positive preliminary effects, achieving an average weight reduction of over 8% after four weeks of treatment in an overweight or obese population, indicating its strong potential for weight loss
Other similar weight loss drugs like Mounjaro or Saxenda are also GLP-1 RAs, but they have different active ingredients
This distinction matters because it means the specific formulation dispensed has not undergone the same approval process as mass-manufactured pharmaceuticals
Cell 27 , 149162 (2007)
This study demonstrated the importance of genetic factors as an element to examine in future studies that evaluate the usefulness of NAC in patients with lung fibrosing diseases [51]
Specifically, GLP-1RAs inhibit energy intake, concurrently elevating energy expenditure, whereas SGLT-2is simultaneously promote energy secretion, and utilization at the same time